Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents.
The eighth volume of this series presents comprehensive reviews of interest to readers interested in the treatment of inflammatory diseases, new antiviral agents and strategies, specific antiprotozoal drugs that work against leishmania and helminthes, and a study on potential agents against American foulbrood in honey bees.
The 7 reviews included in this volume are:
- Monoclonal antibodies as therapeutic agents for inflammatory diseases
- Pharmacotherapy of emerging antiviral agents
- Antiviral activity of vitamin D and COVID-19: current understanding
- Anti-infectives to combat leishmaniasis
- Anthelmintic drug discovery: current situation and future perspectives
- Therapeutic targets for emerging Zika virus infection and vaccines in clinical trials
- Agro-industrial waste: new source of raw material for the control of American foulbrood in honey bees
Audience: Pharmaceutical scientists, medical doctors, virologists, entomologists, epidemiologists
About the Editor:
Atta-ur-Rahman, FRS, Ph.D. in Organic Chemistry from Cambridge University (1968) has 1,232 international publications (45 international patents and 341 books). He received the following awards: Fellow Royal Society (FRS) London (2006), UNESCO Science Prize (1999), Honorary Life Fellow Kings College, Cambridge University (2007), Academician (Foreign Member) Chinese Academy of Sciences (2015), Highest Civil Award for Foreigners of China (Friendship Award, 2014), High Civil Award Austria ("Grosse Goldene Ehrenzeischen am Bande") (2007), Foreign Fellow Chinese Chemical Society (2013), Sc.D. Cambridge University (UK) (1987), TWAS (Italy) Prize (2009). He was the President of Network of Academies of Sciences of Islamic Countries (NASIC), Vice President TWAS (Italy), Foreign Fellow Korean Academy of Science & Technology, President Pakistan Academy of Sciences (2003-2006) and (2011 — 2014). He was the Federal Minister for Science and Technology of Pakistan (2000 2002), Federal Minister of Education (2002) and Chairman Higher Education Commission/Federal Minister (2002-2008), Coordinator General of COMSTECH (01C Ministerial Committee) (1996-2012), and the Editor-in-Chief of Current Medicinal Chemistry.
Chemotherapy, Immunomodulators, Host Protein Targets, Molecular Pathogenesis, Zika Virus, Beta coronavirus, Calcidiol, Biopharmaceuticals Market, Inflammatory Diseases, Monoclonal Antibodies, Therapeutic Agents.
For more Information, Please visit: https://bit.ly/3pCcTlC